Catalyst Pharmaceuticals (CPRX) Interest & Investment Income (2010 - 2014)
Catalyst Pharmaceuticals posted quarterly Interest & Investment Income of $5924.0 for Q3 2014, down 42.59% year-on-year from $10318.0 in Q3 2013, and down 62.37% on a QoQ basis from $15744.0 in Q2 2014.
Catalyst Pharmaceuticals (CPRX) has 5 years of Interest & Investment Income data on file, last reported at $5924.0 in Q3 2014.
- For the quarter ending Q3 2014, Interest & Investment Income fell 42.59% year-over-year to $5924.0; the trailing twelve-month figure through Sep 2014 stood at $76538.0 (up 119.55% YoY), and the FY2013 full-year result was $47421.0, up 216.65% from the prior year.
- Interest & Investment Income for Q3 2014 stood at $5924.0, down from $15744.0 in the prior quarter.
- Across five years, Interest & Investment Income topped out at $32760.0 in Q1 2014 and bottomed at $1317.0 in Q1 2012.
- The 5-year median for Interest & Investment Income is $4480.0 (2010), against an average of $7982.8.
- The widest annual swing landed in 2012, when Interest & Investment Income slumped 58.79%; it then jumped 524.62% in 2013.
- A 5-year view of Interest & Investment Income shows it stood at $3418.0 in 2010, then tumbled by 30.08% to $2390.0 in 2011, then jumped by 299.58% to $9550.0 in 2012, then surged by 131.52% to $22110.0 in 2013, then tumbled by 73.21% to $5924.0 in 2014.
- The last three Interest & Investment Income figures came in at $5924.0 (Q3 2014), $15744.0 (Q2 2014), and $32760.0 (Q1 2014), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 7.90 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 114.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | 305,000.00 |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | - |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 26.60 Mn |
| 10 | Catalyst Pharmaceuticals | 3.82 Bn | 3.07 Bn | 134.92 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 5,924.00 |
| Jun 30, 2014 | 15,744.00 |
| Mar 31, 2014 | 32,760.00 |
| Dec 31, 2013 | 22,110.00 |
| Sep 30, 2013 | 10,318.00 |
| Jun 30, 2013 | 8,526.00 |
| Mar 31, 2013 | 6,467.00 |
| Dec 31, 2012 | 9,550.00 |
| Sep 30, 2012 | 2,744.00 |
| Jun 30, 2012 | 1,365.00 |
| Mar 31, 2012 | 1,317.00 |
| Dec 31, 2011 | 2,390.00 |
| Sep 30, 2011 | 3,169.00 |
| Jun 30, 2011 | 3,312.00 |
| Mar 31, 2011 | 2,114.00 |
| Dec 31, 2010 | 3,418.00 |
| Sep 30, 2010 | 4,480.00 |